E2F1 and breast cancer: The most recent breast cancer GWAS identified a 2–5 fold increased enrichment of risk SNVs in REs, mostly mapping to the binding sites for breast cancer–associated transcription factors including FOXA1, ESR1, GATA3, E2F1, and TCF7L2 [60].